Odenkirk M, Jostes H, Francis K, Baker E
Mol Omics. 2025; .
PMID: 40078081
PMC: 11904469.
DOI: 10.1039/d4mo00261j.
Kim S, Kwon E, Oh J, Kim H, Park S, Jang G
EMBO Rep. 2025; .
PMID: 39962227
DOI: 10.1038/s44319-025-00384-x.
Chen J, Kataoka O, Tsuchiya K, Oishi Y, Takao A, Huang Y
Regen Ther. 2025; 26():889-900.
PMID: 39822341
PMC: 11735927.
DOI: 10.1016/j.reth.2024.09.007.
Odenkirk M, Jostes H, Francis K, Baker E
bioRxiv. 2025; .
PMID: 39803501
PMC: 11722439.
DOI: 10.1101/2024.12.31.630916.
Soma Y, Tohyama S, Kubo A, Yamasaki T, Kabasawa N, Haga K
iScience. 2024; 27(11):111234.
PMID: 39569381
PMC: 11576393.
DOI: 10.1016/j.isci.2024.111234.
Research Progress towards the Effects of Fatty Acids on the Differentiation and Maturation of Human Induced Pluripotent Stem Cells into Cardiomyocytes.
Gao Z, Zhou F, Mu J
Rev Cardiovasc Med. 2024; 24(3):69.
PMID: 39077493
PMC: 11264038.
DOI: 10.31083/j.rcm2403069.
The SWI/SNF ATP-dependent chromatin remodeling complex in cell lineage priming and early development.
Saha D, Animireddy S, Bartholomew B
Biochem Soc Trans. 2024; 52(2):603-616.
PMID: 38572912
PMC: 11088921.
DOI: 10.1042/BST20230416.
Crosstalk between Signaling Pathways and Energy Metabolism in Pluripotency.
Kim K, Kim S, Cha H
Int J Stem Cells. 2024; 18(1):12-20.
PMID: 38494425
PMC: 11867904.
DOI: 10.15283/ijsc23173.
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer.
Yamamoto T, Hayashida T, Masugi Y, Oshikawa K, Hayakawa N, Itoh M
Cancer Res. 2024; 84(7):1065-1083.
PMID: 38383964
PMC: 10982647.
DOI: 10.1158/0008-5472.CAN-23-2266.
Regulation of fatty acid synthase on tumor and progress in the development of related therapies.
Bai R, Cui J
Chin Med J (Engl). 2024; 137(16):1894-1902.
PMID: 38273440
PMC: 11332710.
DOI: 10.1097/CM9.0000000000002880.
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.
Menendez J, Cuyas E, Encinar J, Steen T, Verdura S, Llop-Hernandez A
Mol Oncol. 2023; 18(3):479-516.
PMID: 38158755
PMC: 10920094.
DOI: 10.1002/1878-0261.13582.
Scalable production of homogeneous cardiac organoids derived from human pluripotent stem cells.
Moriwaki T, Tani H, Haga K, Morita-Umei Y, Soma Y, Umei T
Cell Rep Methods. 2023; 3(12):100666.
PMID: 38113855
PMC: 10753388.
DOI: 10.1016/j.crmeth.2023.100666.
Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance.
Stouras I, Vasileiou M, Kanatas P, Tziona E, Tsianava C, Theocharis S
Cells. 2023; 12(23).
PMID: 38067114
PMC: 10705308.
DOI: 10.3390/cells12232686.
Lipid metabolism as a target for cancer drug resistance: progress and prospects.
Wang Z, Wang Y, Li Z, Xue W, Hu S, Kong X
Front Pharmacol. 2023; 14:1274335.
PMID: 37841917
PMC: 10571713.
DOI: 10.3389/fphar.2023.1274335.
Cutting-edge regenerative therapy for Hirschsprung disease and its allied disorders.
Yoshimaru K, Matsuura T, Uchida Y, Sonoda S, Maeda S, Kajihara K
Surg Today. 2023; 54(9):977-994.
PMID: 37668735
DOI: 10.1007/s00595-023-02741-6.
The AT-hook is an evolutionarily conserved auto-regulatory domain of SWI/SNF required for cell lineage priming.
Saha D, Hailu S, Hada A, Lee J, Luo J, Ranish J
Nat Commun. 2023; 14(1):4682.
PMID: 37542049
PMC: 10403523.
DOI: 10.1038/s41467-023-40386-8.
Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments.
Kishino Y, Fukuda K
Biomedicines. 2023; 11(3).
PMID: 36979894
PMC: 10046277.
DOI: 10.3390/biomedicines11030915.
Ketogenic diet in action: Metabolic profiling of pyruvate dehydrogenase deficiency.
Ogawa E, Hishiki T, Hayakawa N, Suzuki H, Kosaki K, Suematsu M
Mol Genet Metab Rep. 2023; 35:100968.
PMID: 36974075
PMC: 10038782.
DOI: 10.1016/j.ymgmr.2023.100968.
Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification.
Al-Akashi Z, Zujur D, Kamiya D, Kato Jr T, Kondo T, Ikeya M
Front Cell Dev Biol. 2023; 11:1089945.
PMID: 36814599
PMC: 9939518.
DOI: 10.3389/fcell.2023.1089945.
In vitro methods to ensure absence of residual undifferentiated human induced pluripotent stem cells intermingled in induced nephron progenitor cells.
Tsujimoto H, Katagiri N, Ijiri Y, Sasaki B, Kobayashi Y, Mima A
PLoS One. 2022; 17(11):e0275600.
PMID: 36378656
PMC: 9665373.
DOI: 10.1371/journal.pone.0275600.